Loading
₹1,153.00
−6.50−0.56%today
Market closed · 7 Oct, 3:30 pm
+16.71%over 1 year
Today's range
₹1,147.60₹1,167.40
52-week range
₹835.50₹1,232.10
Revenue and net profit in ₹ crore, consolidated where the company reports both.
| Year | Revenue | Net profit | Margin | EPS (₹) |
|---|---|---|---|---|
| FY26 | 26,720 | 5,040 | 18.9% | 50.09 |
| FY25 | 22,574 | 4,526 | 20.0% | 44.97 |
| FY24 | 19,022 | 3,860 | 20.3% | 38.14 |
| FY23 | 16,878 | 1,960 | 11.6% | 19.30 |
As of Sep 2026, as a share of all the company's shares.
| Holder | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 75.01% | 75.01% | 75.00% | 75.00% |
| FIIs | 7.05% | 6.88% | 6.95% | 7.06% |
| DIIs | 11.28% | 11.27% | 11.20% | 11.09% |
| of which mutual funds | 6.88% | 5.12% | 4.88% | 4.71% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% |
| Public | 6.66% | 6.83% | 6.86% | 6.85% |
From the company's quarterly filings with NSE. FIIs are foreign institutions; DIIs are Indian ones such as mutual funds, insurers and banks.
Healthcare companies in the Nifty 500 closest in size.
| Company | Price (₹) | Change | Market cap (₹ cr) |
|---|---|---|---|
| Zydus Lifesciences Ltd.ZYDUSLIFE · this stock | 1,153.00 | −0.56% | 1,15,012 |
| Apollo Hospitals Enterprise Ltd.APOLLOHOSP | 7,917.00 | +0.03% | 1,13,834 |
| Laurus Labs Ltd.LAURUSLABS | 2,052.80 | +0.14% | 1,10,915 |
| Cipla Ltd.CIPLA | 1,327.20 | −0.97% | 1,07,221 |
| Mankind Pharma Ltd.MANKIND | 2,500.00 | 0.00% | 1,03,261 |
| Dr. Reddy's Laboratories Ltd.DRREDDY | 1,203.80 | −0.35% | 1,00,476 |
| Aurobindo Pharma Ltd.AUROPHARMA | 1,682.00 | −0.64% | 96,779 |
Price and volume from NSE; key figures and results from Yahoo Finance; shareholding and corporate actions from the company's NSE filings. Figures can run behind the exchange. For information only, not a recommendation to invest.